MnDRIVE advances the University of Minnesota’s research strengths through state investment to solve Minnesota’s greatest challenges.
During the current legislative session, the University will request funding from the state Legislature to expand MnDRIVE — or Minnesota’s Discovery, Research and InnoVation Economy — into four new research areas: fighting cancer, strengthening communities, cleaning water and advancing data.
Check out the video below to learn about highlights from current MnDRIVE research and to find out more about the program’s proposed expansion.
A University of Minnesota startup recently attracted a major investment to support continued development of drug therapies that make cancer treatments more effective.
ApoGen Biotechnologies Inc., launched in October 2014, announced last month that it had received $7 million from life science investment firm Accelerator Corporation to continue developing a new class of drugs that slows the evolution of cancer cells and to move these treatments toward clinical trials. ApoGen is based on discoveries by two U researchers: Reuben Harris, Ph.D., professor of biochemistry, molecular biology and biophysics; and Daniel Harki, Ph.D., assistant professor of medicinal chemistry. John Santini Jr., Ph.D., is the company’s president and CEO.
Cancer therapies often become less effective over time as cancer cells become resistant to treatment. ApoGen’s drugs are designed to block a key enzyme that causes drug resistance, potentially making current and future treatments more effective. Continue reading
Allen Levine, Ph.D., has more than a passing familiarity with the University of Minnesota’s research enterprise — in one capacity or another, he has been connected to the U for more than 45 years.
Levine, a professor in the Department of Food Science and Nutrition and adjunct in the Department of Psychiatry, began his role as the U’s new interim vice president for research this week. He previously served as vice provost for faculty and academic affairs, as well as dean of the College of Food, Agricultural and Natural Resource Sciences. As head of the Office of the Vice President for Research, Levine will oversee the University’s $900 million research enterprise across all its campuses and facilities, including the administration of sponsored projects, research compliance and regulatory offices, and offices dedicated to economic development and technology commercialization.
“In my new position, I look forward to keeping the University’s research enterprise moving forward and preparing the office for its next permanent director,” he said. “Since arriving, I have found the staff at OVPR to be knowledgeable and well suited to the important work they do for the U.” Continue reading
Tiger at night, caught in a camera trap in Nepal. Photo credit: David Smith.
Few tiger biologists venture into dens to photograph and collect data on cubs. But University of Minnesota tiger researcher David Smith has done it twice, once with the mother just 200 yards away.
Using radio and GPS collars, Smith has tracked tigers for 40 years with one goal in mind: to achieve larger and more secure tiger populations by keeping their prey abundant and their habitat connected rather than patchy. This matters because top predators are critical to ecosystem health.
So are Smith’s graduate students. Most come from Nepal, Thailand, Bangladesh, Cambodia, China, Taiwan or the Philippines. Degrees completed, they return home and mobilize local people for conservation efforts.
After a traumatic injury, every second counts. Whether wounded on the battlefield or hurt in a car crash, someone who has been severely injured needs to reach a hospital as soon as possible. But the farther away they are from one, the harder it is for first responders to get them there within the “golden hour” — the short window of time when life-saving medical treatments are most likely to succeed.
A drug therapy developed by three University of Minnesota researchers could extend this window, giving patients more time to reach the emergency room. The treatment, called BHB/M, is designed to be delivered by IV into the veins of someone suffering from hemorrhagic shock — when the body loses a severe and potentially fatal amount of blood — to help stop their organs from shutting down. Each year, between 300,000 and 400,000 people in the U.S. suffer from hemorrhagic shock. Greg Beilman, M.D., professor of surgery with the U of M Medical School and one of the BHB/M researchers, estimates that 45,000 to 60,000 of those people die from their severe blood loss.
The University of Minnesota’s Grant-in-Aid of Research, Artistry and Scholarship Program promotes the research, scholarly and artistic activities of faculty and supports academic excellence throughout the University. Administered through the Office of the Vice President for Research, the Grant-in-Aid program provides seed funding for a wide range of projects in five funding categories.
Timeline to apply:
Jan. 3, 2017 Start accepting applications
Feb. 6, 2017 Deadline for applications to be routed to approvers
Feb. 9, 2017 Deadline for approvers to submit final applications to OVPR
Visit Grant-in-Aid to learn more about the funding categories, eligibility requirements, how to apply and see samples of some exemplary proposals.
Questions? Contact the Research Advancement office: firstname.lastname@example.org or 612-625-2356.
For the University of Minnesota, the completion of 2016 marks another year of advancing knowledge, forming new partnerships and making groundbreaking discoveries.
The Inquiry blog, led by the Office of the Vice President for Research, set out to explore such strides in research and innovation when it launched more than two years ago. Its path has since woven across departments and disciplines, delving into everything from varieties of wine grapes that withstand the cold to the microscopic communities of bacteria that live inside of us.
Before we bid farewell to 2016, here’s a look back at the year’s 10 most-read Inquiry stories. Continue reading
In 2013, Brian Herman, Ph.D., joined the University of Minnesota as its vice president for research.
During his tenure, Herman helped the U’s research enterprise continue to grow by diversifying funding sources, increasing public-private partnership and enhancing protections for human research participants. His recent report to the Board of Regents highlighted, among other accomplishments, research funding at record levels and thriving technology commercialization and economic development efforts.
Now, four years later, Herman is preparing to transition out of the Office of the Vice President for Research and join the College of Science and Engineering faculty in the Department of Biomedical Engineering. In the Q&A below, Herman discusses the progress of the U’s research enterprise and the future of public research universities. Continue reading
The University of Minnesota’s research enterprise continues to grow, driven by greater diversification of funding sources and enhanced public-private partnership.
At today’s Board of Regents meeting, Vice President for Research Brian Herman delivered this message as part of his annual Status of University Research and Commercialization of Intellectual Property report. The report summarized the U’s research metrics for the 2016 fiscal year, documenting trends in research productivity, scholarship and technology commercialization. It also noted the progress of strategic priorities that build the University’s research strength and work to eliminate barriers to research success. Continue reading
Each year, the federal government offers about $2.5 billion in funding to help small businesses bring new innovations to market — including those originating from public research institutions like the University of Minnesota. The complex applications for such funding, however, can be challenging to understand and to navigate.
The MN-SBIR program aims to shed light on the process. The program assists seed, early stage, emerging and existing firms of up to 500 employees in accessing federal funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The office provides confidential, one-on-one guidance and advice in business development and technology commercialization to help those applying for SBIR or STTR grants or contract. For University researchers, these funding sources can provide much needed funds to help bring cutting-edge discoveries beyond the lab and toward commercialization.
“SBIR and STTR funding supports research and development in science and technology across the spectrum of disciplines,” said Pat Dillon, director of MN-SBIR. “These federal funding sources, often in addition to angel investment or venture capital, but not necessarily, will help startups and small businesses continue to develop the technology and move it towards commercialization.” Continue reading
A new, national initiative based at the University of Minnesota will bring experts together from across disciplines to address complex health issues at the community level.
Earlier this fall, the U of M was selected as the national center for the Robert Wood Johnson Foundation’s Interdisciplinary Research Leaders program. As the program lead, the U of M will work to bring together a wide variety of research experts to conduct action-oriented public health studies in communities across the country, while also cultivating these experts’ roles as future leaders in interdisciplinary research. The innovative, two-year research projects in IRL aim to drive change in communities and advance policies that share a central goal — building a culture of health.
“A culture of health is about helping people live healthier, more vibrant lives now so they don’t need as much medical care down the road,” said Michael Oakes, Ph.D., professor of epidemiology and community health with the School of Public Health. “These projects make good use of translational, applied research to help create new social norms that benefit our society’s well-being, such as regular exercise, work-life balance and healthy social environments.” Continue reading
Filing for a patent on a research discovery is more than just a way to protect the intellectual property behind it. Patents are often a crucial step toward moving breakthroughs beyond the lab and into the market, where they can benefit society.
Congratulations to the U of M researchers who were recently awarded patents for their discoveries. To learn more about reporting an invention, contact the Office for Technology Commercialization at 612-624-0550 or email@example.com. Continue reading